Rating:
Aum
₹5,870.00 Cr
Expense Ratio
1.99%
Exit Load
0.50%
Min. Investment
₹5,000.00
Min. SIP
₹500.00
Launch Date
31 Dec 2004
| Period | Absolute(%) | Annualised(%) |
|---|---|---|
| 1 Month | +10.6% | -- |
| 3 Months | +4.01% | -- |
| 6 Months | +16.56% | -- |
| 1 Year | +23.72% | +23.72% |
| 2 Years | -- | +14.06% |
| 3 Years | +87.37% | +23.28% |
| 5 Years | +139.12% | +19.05% |
| Since Launch | +2334.05% | +15.71% |
| Name | Value (₹Cr) | Holding % |
|---|---|---|
| Sun Pharmaceutical Industries | 639.98 | 10.55 |
| Divi's Laboratories | 508.56 | 8.38 |
| Max Healthcare Institute | 301.06 | 4.96 |
| Acutaas Chemicals | 300.27 | 4.95 |
| Apollo Hospitals Enterprise | 295.17 | 4.87 |
| Laurus Labs | 288.66 | 4.76 |
| Cipla | 264.75 | 4.36 |
| Treps | 251.39 | 4.14 |
| Torrent Pharmaceuticals | 249.13 | 4.11 |
| Aurobindo Pharma | 188.32 | 3.10 |
Rating:
Risk
Return
1.13
Sharpe Ratio
14.37%
Std. Deviation
5.23%
Tracking Error
3.14%
Alpha
0.88
Beta
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| SBI Healthcare Opportunities Fund Regular Growth | +23.72% | +23.28% | +19.05% |
| ICICI Prudential Healthcare Fund Regular Growth | +8.18% | +20.39% | +16.87% |
| DSP Healthcare Fund Regular Growth | +15.58% | +18.86% | +15% |
| HDFC Pharma and Healthcare Fund Regular Growth | +28.41% | +28.92% | -- |
| Nippon India Pharma Fund - Growth | +11.76% | +16.55% | +13.76% |
Results are calculated on CAGR basis
To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
The SBI Healthcare Opportunities Fund Regular Growth has an AUM of 5870.00 crores & has delivered CAGR of 19.05 in the last 5 years. The fund has an exit load of 0.50% and an expense ratio of 1.99%. The minimum investment in SBI Healthcare Opportunities Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 500.
As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.
The fund has a present cash holding of %. The top holdings of the fund include Sun Pharmaceutical Industries, Divi's Laboratories, Max Healthcare Institute, Acutaas Chemicals.
The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Chemical Manufacturing, Major Drugs.
Some of the similar funds are SBI Healthcare Opportunities Fund Regular Growth, ICICI Prudential Healthcare Fund Regular Growth, DSP Healthcare Fund Regular Growth, HDFC Pharma and Healthcare Fund Regular Growth, Nippon India Pharma Fund - Growth. SBI Healthcare Opportunities Fund Regular Growth has a sharpe ratio of 1.13 & a standard deviation of 14.37%.
According to the morning star rating SBI Healthcare Opportunities Fund Regular Growth has a Medium risk & Exceptional return.
SBI Healthcare Opportunities Fund Regular Growth is managed by Tanmaya Desai.
The expense ratio of SBI Healthcare Opportunities Fund Regular Growth is 1.99%.
The 5 year annualized return on SBI Healthcare Opportunities Fund Regular Growth is 19.05% & it has generated 23.72% in the last 1 year.
The minimum investment in SBI Healthcare Opportunities Fund Regular Growth is 5000 Rs.
SBI Healthcare Opportunities Fund Regular Growth has an AUM of 5870.00 crores.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.